These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 581483)

  • 21. Immunoprecipitation of TSH-TSH receptor complexes.
    Parkes AB; Kajita Y; Buckland PR; Howells RD; Rickards CR; Creagh FM; Rees Smith B
    Clin Endocrinol (Oxf); 1985 Apr; 22(4):511-20. PubMed ID: 2985304
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differences between thyrotropin receptor antibody bioactivity and inhibition of 125I-bovine thyrotropin binding.
    Wallaschofski H; Kaczmarek M; Miehle K; Hentschel B; Paschke R
    Thyroid; 2000 Oct; 10(10):897-907. PubMed ID: 11081256
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A case of Graves' disease with false hyperthyrotropinemia who developed silent thyroiditis.
    Iitaka M; Ishii J; Ishikawa N; Yoshimura H; Momotani N; Saitou H; Ito K
    Endocrinol Jpn; 1991 Dec; 38(6):667-71. PubMed ID: 1688049
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Measurement of thyroid-stimulating immunoglobulins by incorporation of tritiated-adenine into intact FRTL-5 cells: a viable alternative to radioimmunoassay for the measurement of cAMP.
    Leedman PJ; Frauman AG; Colman PG; Michelangeli VP
    Clin Endocrinol (Oxf); 1992 Dec; 37(6):493-9. PubMed ID: 1363083
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sensitive thyrotropin and thyrotropin-receptor antibody determinations one month after discontinuation of antithyroid drug treatment as predictors of relapse in Graves' disease.
    Quadbeck B; Hoermann R; Roggenbuck U; Hahn S; Mann K; Janssen OE;
    Thyroid; 2005 Sep; 15(9):1047-54. PubMed ID: 16187913
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Graves' immunoglobulins protect the human TSH receptor: further evidence for TSH receptor antibodies in Graves' disease.
    Davies TF; Platzer M
    Clin Endocrinol (Oxf); 1983 Oct; 19(4):427-35. PubMed ID: 6313261
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Clinical studies on abnormal thyroid stimulators in patients with Graves' disease. I. A sensitive assay for thyroid-stimulating antibodies using cultured porcine thyroid cells and polyethylene glycol precipitation of serum].
    Uno C; Nishikawa M
    Nihon Naibunpi Gakkai Zasshi; 1988 Mar; 64(3):193-205. PubMed ID: 2899523
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Regulation mechanisms of the pituitary-thyroid axis in normal subjects and patients with Graves' disease using a highly sensitive TSH assay].
    Takagi S; Yamauchi K; Mori Y; Tanaka H; Miura Y; Takatsuki K; Tomita A; Funahashi H; Mizuno S; Ishizuki Y
    Kaku Igaku; 1986 Aug; 23(8):1043-53. PubMed ID: 3784128
    [No Abstract]   [Full Text] [Related]  

  • 29. Anti-bovine TSH antibodies in patients with Graves' disease and primary myxedema.
    Cho BY; Shong YK; Lee HK; Koh CS; Min HK
    Thyroidology; 1989 Apr; 1(1):31-7. PubMed ID: 2484905
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A new serum-based assay for fat cell-binding immunoglobulins: application to the detection of the thyrotropin receptor antibodies of Graves' disease.
    Shinozawa T; Villadolid MC; Ingbar SH
    J Clin Endocrinol Metab; 1986 Jan; 62(1):10-5. PubMed ID: 2999174
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Peripheral parameters of oxidative stress in patients with infiltrative Graves' ophthalmopathy treated with corticosteroids.
    Bednarek J; Wysocki H; Sowiński J
    Immunol Lett; 2004 May; 93(2-3):227-32. PubMed ID: 15158621
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of serum prolactin and thyrotropin responses to thyrotropin-releasing hormone in patients with Graves' ophthalmopathy.
    Chopra IJ; Chopra U; Vanderlaan WP; Solomon DH
    J Clin Endocrinol Metab; 1974 Apr; 38(4):683-7. PubMed ID: 4206832
    [No Abstract]   [Full Text] [Related]  

  • 33. Effect of thyrotropin-releasing hormone on serum thyroid hormones: a study in the patients with untreated and treated Graves' disease and subacute thyroiditis.
    Sato A; Yamada T; Aizawa T; Ichikawa K; Komiya I; Takasu N; Takemura Y
    J Clin Endocrinol Metab; 1995 Jul; 80(7):2173-7. PubMed ID: 7608274
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasma immunoreactive TSH: spurious elevation due to antibodies to bovine TSH which cross-react with human TSH.
    Frohman LA; Baron MA; Schneider AB
    Metabolism; 1982 Aug; 31(8):834-40. PubMed ID: 6808295
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A thyrotropin radioimmunoassay kit evaluated vs two reference assays.
    Bigos ST; Pekary AE; MacLean J; Pierce CE; Reed AW; Hershman JM
    Clin Chem; 1984 Mar; 30(3):437-9. PubMed ID: 6697491
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Failure of pituitary response to thyrotrophin-releasing hormone in euthyroid Graves' disease.
    Lawton NF; Ekins RP; Nabarro JD
    Lancet; 1971 Jul; 2(7714):14-6. PubMed ID: 4103663
    [No Abstract]   [Full Text] [Related]  

  • 37. [Changes in serum T3, T4 and TSH before and after the T3-suppression test in patients treated for Graves' disease (author's transl)].
    Tamai H; Suematsu H; Esaki M; Kurakawa N; Aoki H
    Nihon Naibunpi Gakkai Zasshi; 1977 Jan; 53(1):17-27. PubMed ID: 72007
    [No Abstract]   [Full Text] [Related]  

  • 38. [Prediction of postpartum relapse of Graves' thyrotoxicosis and the development of neonatal Graves' disease by the highly sensitive TSH immunoradiometric assay].
    Takeoka K; Amino N; Tamaki H; Aozasa M; Tachi J; Iwatani Y; Mori M; Tanizawa O; Miyai K
    Rinsho Byori; 1988 Apr; 36(4):455-8. PubMed ID: 3404742
    [No Abstract]   [Full Text] [Related]  

  • 39. [Studies on the radioreceptor assay of TSH: the properties of TSH-binding inhibitor immunoglobulins (TBII) in patients with Graves' disease (author's transl)].
    Endo K
    Nihon Naibunpi Gakkai Zasshi; 1979 Oct; 55(10):1261-74. PubMed ID: 228998
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum immunoglobulin G4 levels and Graves' disease phenotype.
    Martin CS; Sirbu AE; Betivoiu MA; Florea S; Barbu CG; Fica SV
    Endocrine; 2017 Feb; 55(2):478-484. PubMed ID: 27819113
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.